Journal of Radiopharmaceuticals and Molecular Probes (대한방사성의약품학회지)

Korean Society of Radiopharmaceuticals and Molecular Probes (대한방사성의약품학회)
권호 표지
DOI QR코드

DOI QR Code

Consecutive automated production of carbon-11 labeled radiopharmaceuticals by sharing 11C-methylation reagent from one 11C-synthetic module

  • Park, Hyun Sik (Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Lee, Hong Jin (Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • An, Hyun Ho (Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Moon, Byung Seok (Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Lee, Byung Chul (Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Kim, Sang Eun (Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
  • Received : 2016.11.24
  • Accepted : 2016.12.13
  • Published : 2016.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Increasing clinical demand for carbon-11 labeled radiopharmaceuticals has triggered technological advances in fields of radiochemistry and automated modules. Even though carbon-11 has a short half-life ($t_{1/2}=20.4min$), the consecutive second production of carbon-11 labeled radiopharmaceutical in one $^{11}C$-synthetic module should be delayed at least over 4 h to avoid the high radiation exposure. We herein aimed to produce two different carbon-11 labeled radiopharmaceuticals ([$^{11}C$]PIB and [$^{11}C$]methionine) by sharing of [$^{11}C$]methylation source in one $^{11}C$-synthetic module. The synthesis of $^{11}C$-labeling reagents ($[^{11}C]CH_3I$ or $[^{11}C]CH_3OTf$) is fully automated using the commercial TRACERlab $FX_{C-pro}$ module and is readily adaptable to $^{11}C$-labeling reactor for [$^{11}C$]PIB as well as another $^{11}C$-labeling apparatus for [$^{11}C$]methionine via the three-way valve. After completing the [$^{11}C$]PIB production, the re-synthesized $[^{11}C]CH_3I$ was passed through the three-way valve connected the polyetheretherketone (PEEK) line and loaded into the C18 Sep-Pak cartridge including the methionine precursor. The labeled product [^${11}C$]methionine was purified by a simple cartridge separation and reformulated into saline. The radiochemical yield of [$^{11}C$]PIB and [$^{11}C$]methionine were $5.3{\pm}0.6%$ and $18.7{\pm}0.8%$ (n.d.c.), respectively, with over 97% of radiochemical purity. The specific activity of [$^{11}C$]PIB was over $110GBq/{\mu}mol$. Total production time of two radiopharmaceuticals needs about 2 h from $1^{st}$ beam irradiation including quality control tests. Final [$^{11}C$]PIB and [$^{11}C$]methionine were satisfied all quality control test standards.

Keywords

References

  1. Choe YS. Radiolabeling methods used for preparation of molecular probes. Korean J Nucl Med 2004;38:121-130.
  2. Miller PW, Long NJ, Vilar R, Gee AD. Synthesis of $^{11}C$, $^{18}F$, $^{15}O$ and $^{13}N$ radiolabels for positron emission tomography. Angew Chem Int Ed 2008;47:8998-9033. https://doi.org/10.1002/anie.200800222
  3. Vallabhajosula S. Molecular Imaging: Radiopharmaceuticals for PET and SPECT. Springer Dordrecht Heidelberg; 2009, 45-58.
  4. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheval I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306-319. https://doi.org/10.1002/ana.20009
  5. Mitterhauser M, Wadsak W, Krcal A, Schmaljohann J, Eidherr H, Schmid A, Viernstein H, Dudczak R, Kletter K. New aspects on the preparation of [$^{11}C$]Methionine-a simple and fast online approach without preparative HPLC. Appl Radiat Isotope 2005;62:441-445. https://doi.org/10.1016/j.apradiso.2004.07.006
  6. Lee BC, Lee HJ, Park JH, Moon BS, Kim SE, Lee WK, Jung KI, Chae SK, Kim JH. Intensification of the KOTRON-13 cyclotron by optimizing the ion source. J Korean Phys Soc 2010;57:1376-1380. https://doi.org/10.3938/jkps.57.1376
  7. Moon BS, Lee HJ, Lee WK, Hur MG, Yang SD, Lee BC, Kim SE. Development of an additive $[^{11}C]CO_2$ target system in the KOTRON-13 cyclotron and its application for [$^{11}C$] radiopharmaceutical production. Nucl Instrum Meth Phys Res B 2015;356-357:1-7. https://doi.org/10.1016/j.nimb.2015.04.022
  8. Park JH, Lee HJ, Park HS, Jo BM, Moon BS, Lee IW, Lee BC, Kim SE. Development of the 'one-click' $^{18}F-NaF$ module. J Nucl Med 2014;55 (suppl. 1):p2517.